Tenet Healthcare's (THC) stock soared 5.02% in intraday trading on Thursday, February 13, 2025, following the company's impressive fourth-quarter 2024 earnings report and upbeat 2025 guidance.
The healthcare services company reported fourth-quarter adjusted earnings per share of $3.44, surpassing analysts' estimates by 17.4% and its own guidance range. The strong quarterly performance was driven by higher same-hospital admissions, a favorable payer mix, increased Medicaid supplemental revenues, lower operating expenses, and facility buyouts and service line expansions in the Ambulatory Care unit.
For fiscal 2025, Tenet Healthcare provided robust guidance, projecting adjusted EBITDA growth of 7% at the midpoint, driven by anticipated growth in same-facility revenues, effective operational execution, and additional sites of care joining the Ambulatory Care portfolio. The company also expects continued strength in demand, high acuity growth, and further contributions from recent investments and partnerships in the Hospital segment.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。